50 related articles for article (PubMed ID: 21108890)
21. Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer.
Zarogoulidis K; Mylonaki E; Kakavelas P; Zarogoulidis P; Tsiouda T; Rapti E; Lithoxopoulou H; Zarogoulidou V; Kontakiotis T;
Lung Cancer; 2009 Nov; 66(2):226-30. PubMed ID: 19321222
[TBL] [Abstract][Full Text] [Related]
22. Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer.
Lee YY; Lee JW; Park HS; Song TJ; Kim MK; Choi CH; Kim TJ; Lee JH; Bae DS; Kim BG
Gynecol Oncol; 2010 Oct; 119(1):87-91. PubMed ID: 20580417
[TBL] [Abstract][Full Text] [Related]
23. [Combination of docetaxel and cisplatin in the treatment of advanced non-small cell lung cancer].
Liu H; Hou M; Zhu J; Li L; Qiu M; Yan X
Zhongguo Fei Ai Za Zhi; 2002 Oct; 5(5):352-3. PubMed ID: 21329604
[TBL] [Abstract][Full Text] [Related]
24. Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group study.
Miller DS; Blessing JA; Lentz SS; McMeekin DS
Cancer; 2003 Oct; 98(8):1664-9. PubMed ID: 14534883
[TBL] [Abstract][Full Text] [Related]
25. [A randomized study of docetaxel plus cisplatin versus paclitaxel plus cisplatin in previously untreated advanced non-small cell lung cancer.].
Zhang S; Wang J; Wang Q; Yang X; Hu F; Li X; Gu Y; Wang H
Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):110-4. PubMed ID: 20727278
[TBL] [Abstract][Full Text] [Related]
26. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R
Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149
[TBL] [Abstract][Full Text] [Related]
27. A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors.
Seiden MV; Ng SW; Supko JG; Ryan DP; Clark JW; Lynch T; Huang KC; Kwiatkowski D; Skarin A; Eder JP
Clin Cancer Res; 2002 Mar; 8(3):691-7. PubMed ID: 11895897
[TBL] [Abstract][Full Text] [Related]
28. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
29. [Combination chemotherapy with gemcitabine plus cisplatin in the treatment of advanced non-small cell lung cancer.].
Li L; Zhang L; Li J; Wang M; Cui Z
Zhongguo Fei Ai Za Zhi; 1999 Dec; 2(2):83-6. PubMed ID: 20929636
[TBL] [Abstract][Full Text] [Related]
30. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
31. Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.
Reck M; Groth G; Buchholz E; Goetz E; Gatzemeier U; Manegold C
Lung Cancer; 2005 Jun; 48(3):409-13. PubMed ID: 15893010
[TBL] [Abstract][Full Text] [Related]
32. [Clinical study of navelbine combined with cisplatin in the treatment of advanced non-small cell lung cancer].
He Y
Zhongguo Fei Ai Za Zhi; 2004 Dec; 7(6):517-9. PubMed ID: 21251412
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
Chen CH; Lin CM; Kao KC; Chang JW; Tsao TC
Chang Gung Med J; 2007; 30(3):249-55. PubMed ID: 17760276
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma.
Gronlund B; Hansen HH; Høgdall C; Engelholm SA
Cancer; 2002 Oct; 95(8):1656-62. PubMed ID: 12365013
[TBL] [Abstract][Full Text] [Related]
35. Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial.
Stathopoulos GP; Katis C; Tsavdaridis D; Dimitroulis J; Karaindros D; Stathopoulos J; Dimou E
Cancer Chemother Pharmacol; 2006 Oct; 58(4):555-60. PubMed ID: 16520987
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic effect of taxol combined with cisplatin for pulmonary metastasis from breast cancer].
Zhang G; Li F
Zhongguo Fei Ai Za Zhi; 2007 Feb; 10(1):51-3. PubMed ID: 21110935
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of advanced and recurrent cervical cancer treated with cisplatin and generic topotecan: retrospective analysis in a tertiary care hospital in Thailand.
Suprasert P; Charoenkwan K; Cheewakriangkrai C
J Gynecol Oncol; 2010 Dec; 21(4):237-40. PubMed ID: 21278885
[TBL] [Abstract][Full Text] [Related]
38. [Topotecan in combination with cisplatin in the treatment of recurrent small cell lung cancer].
Zhang Y; Feng B; Sun Y; Zhang B; Fan K; Han M
Zhongguo Fei Ai Za Zhi; 2005 Aug; 8(4):317-8. PubMed ID: 21108890
[TBL] [Abstract][Full Text] [Related]
39. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
Ardizzoni A; Manegold C; Debruyne C; Gaafar R; Buchholz E; Smit EF; Lianes P; ten Velde G; Bosquee L; Legrand C; Neumaier C; King K;
Clin Cancer Res; 2003 Jan; 9(1):143-50. PubMed ID: 12538462
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
